313 related articles for article (PubMed ID: 24097106)
1. Molecular biomarkers in pediatric glial tumors: a needed wind of change.
Fontebasso AM; Bechet D; Jabado N
Curr Opin Oncol; 2013 Nov; 25(6):665-73. PubMed ID: 24097106
[TBL] [Abstract][Full Text] [Related]
2. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
3. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Brain Tumors: Genomics and Epigenomics Pave the Way.
Fontebasso AM; Jabado N
Crit Rev Oncog; 2015; 20(3-4):271-99. PubMed ID: 26349420
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
7. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
8. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
9. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
10. Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.
Lehtinen B; Raita A; Kesseli J; Annala M; Nordfors K; Yli-Harja O; Zhang W; Visakorpi T; Nykter M; Haapasalo H; Granberg KJ
BMC Cancer; 2017 May; 17(1):310. PubMed ID: 28468611
[TBL] [Abstract][Full Text] [Related]
11. Genetics, prognosis and therapy of central nervous system tumors.
Watkins D; Rouleau GA
Cancer Detect Prev; 1994; 18(2):139-44. PubMed ID: 8025896
[TBL] [Abstract][Full Text] [Related]
12. Pathological classification of brain tumors.
Pollo B
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):103-11. PubMed ID: 22617234
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtypes of glioma identified by genome-wide methylation profiling.
Kloosterhof NK; de Rooi JJ; Kros M; Eilers PH; Sillevis Smitt PA; van den Bent MJ; French PJ
Genes Chromosomes Cancer; 2013 Jul; 52(7):665-74. PubMed ID: 23629961
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.
Bergthold G; Bandopadhayay P; Hoshida Y; Ramkissoon S; Ramkissoon L; Rich B; Maire CL; Paolella BR; Schumacher SE; Tabak B; Ferrer-Luna R; Ozek M; Sav A; Santagata S; Wen PY; Goumnerova LC; Ligon AH; Stiles C; Segal R; Golub T; Grill J; Ligon KL; Chan JA; Kieran MW; Beroukhim R
Neuro Oncol; 2015 Nov; 17(11):1486-96. PubMed ID: 25825052
[TBL] [Abstract][Full Text] [Related]
15. Advances in the biology and treatment of pediatric central nervous system tumors.
Vitanza NA; Cho YJ
Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors.
Alonso M; Hamelin R; Kim M; Porwancher K; Sung T; Parhar P; Miller DC; Newcomb EW
Cancer Res; 2001 Mar; 61(5):2124-8. PubMed ID: 11280776
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of malignant gliomas.
Belda-Iniesta C; de Castro Carpeño J; Casado Sáenz E; Cejas Guerrero P; Perona R; González Barón M
Clin Transl Oncol; 2006 Sep; 8(9):635-41. PubMed ID: 17005465
[TBL] [Abstract][Full Text] [Related]
18. Genomic discoveries in adult astrocytoma.
Wang J; Bettegowda C
Curr Opin Genet Dev; 2015 Feb; 30():17-24. PubMed ID: 25616158
[TBL] [Abstract][Full Text] [Related]
19. Pediatric high-grade glioma: current molecular landscape and therapeutic approaches.
Braunstein S; Raleigh D; Bindra R; Mueller S; Haas-Kogan D
J Neurooncol; 2017 Sep; 134(3):541-549. PubMed ID: 28357536
[TBL] [Abstract][Full Text] [Related]
20. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
Ivliev AE; 't Hoen PA; Sergeeva MG
Cancer Res; 2010 Dec; 70(24):10060-70. PubMed ID: 21159630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]